STOCK TITAN

Johnson & Johnson to Participate in the Raymond James 45th Annual Institutional Investors Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Johnson & Johnson (JNJ) will participate in the Raymond James 45th Annual Institutional Investors Conference. Ahmet Tezel, Company Group Chairman, MedTech R&D, will represent the Company in a session scheduled at 2:15 p.m. (Eastern Time). The live audio webcast will be available on the JNJ website. This indicates the company's focus on investor engagement and transparency.
Positive
  • None.
Negative
  • None.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will participate in the Raymond James 45th Annual Institutional Investors Conference on Tuesday, March 5th, at the JW Marriott Orlando Grande Lakes, Orlando, FL. Ahmet Tezel, Company Group Chairman, MedTech R&D will represent the Company in a session scheduled at 2:15 p.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

Media contact:

media-relations@its.jnj.com

Investor contact:

investor-relations@its.jnj.com

Source: Johnson & Johnson

FAQ

When is the Raymond James 45th Annual Institutional Investors Conference and where will it take place?

The conference will take place on Tuesday, March 5th, at the JW Marriott Orlando Grande Lakes, Orlando, FL.

Who will represent Johnson & Johnson at the conference?

Ahmet Tezel, Company Group Chairman, MedTech R&D, will represent the Company.

Where can investors access the live audio webcast of the conference?

Investors can access the webcast on the Johnson & Johnson website at www.investor.jnj.com.

When will the audio webcast replay be available?

The audio webcast replay will be available approximately 48 hours after the webcast.

Johnson & Johnson

NYSE:JNJ

JNJ Rankings

JNJ Latest News

JNJ Stock Data

353.35B
2.41B
0.09%
72.76%
0.78%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
NEW BRUNSWICK